GVA The gold standard for diagnosing and following patients with inflammatory bowel
disease (IBD) has been endoscopy, which is quite invasive. While a flexible sigmoidoscopy …

There is currently no single test available to confidently diagnose cases of inflammatory
bowel disease (IBD). Physicians rely on a number of diagnostic tools, including clinical …

Inflammatory bowel diseases (IBD) are idiopathic, remitting and relapsing diseases causing
chronic inflammation of intestine. Initial diagnosis, assessment of disease activity, and …

In the diagnostic work up of a patient suspected of having inflammatory bowel disease (IBD),
biomarkers are helpful in prioritizing further examinations, including endoscopy, and/or in …

The number of patients with inflammatory bowel disease (IBD) is increasing worldwide.
Endoscopy is the gold standard to assess the condition of IBD. The problem with this …

The role of biomarkers in the diagnosis of inflammatory bowel disease is not fully
characterized. C-reactive protein has a short half-life and elevates quickly after the onset of …

Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …

Our current approach to diagnosing inflammatory bowel diseases (IBDs) includes invasive
testing such as endoscopy, colonoscopy, radiologic imaging, and histopathology. The cost …

There is currently no gold standard test for the diagnosis of inflammatory bowel disease
(IBD). Physicians must rely on a number of diagnostic tools including clinical and …

Background: While predictors of disease course in inflammatory bowel diseases (IBD) are
not accurate, we adapt therapies reactively, after objective demonstration of the presence of …